低分子CMO/CDMOの世界市場レポート 2024

低分子CMO/CDMOの市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には7.7%の年間複合成長率（CAGR）で680億4,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、医薬品パイプラインの増加、製薬業務の世界化、柔軟な製造ソリューションに対する需要の増加、規制遵守の専門知識、バイオ医薬品の統合などの要因に起因すると考えられます。予測期間中に予想される主な動向には、持続可能で環境に優しい製造方法の採用、業界内の協力とパートナーシップの強化、個別化医療とニッチ治療への注力、仮想および仮想現実企業の出現、デジタル技術の統合、迅速対応製造戦略の導入などがあります。

医薬品の需要の高まりにより、低分子CMO/CDMO市場は成長すると予想されています。製薬産業には、政府と民間のさまざまな主体による医薬品の発見、開発、生産が含まれます。製薬業界における低分子CMO/CDMOサービスは、低分子医薬品の開発、製造、包装などの業務をアウトソーシングするために活用されています。このアウトソーシングにより、製薬会社はコストを削減し、時間を節約し、プロセスを合理化することができます。 2021年 5月のIQVIA Inc.のレポートによると、米国の医薬品への予想総支出は2020年の3,590億米ドルから3%のCAGRを反映して、2025年までに3,800億米ドルから4,000億米ドルの範囲になると予想されています。この予測は次のことを示しています。医薬品の需要が高まり、その結果、低分子CMO/CDMO市場の成長が促進されます。

低分子CMO/CDMO市場の大手企業は、上海の最先端の低分子プラットフォームなど、CDMOサービスを強化するための革新的な技術に注力しています。このプラットフォームは、低分子医薬品のより効率的な開発と生産を目的とした最先端の技術革新を表しています。 2023年 6月、中国に本拠を置く製薬会社ポートンファーマソリューションズ社は、最先端の小分子プラットフォームを上海で立ち上げました。このプラットフォームは、先進技術と方法論を組み合わせて総合的なアプローチを採用し、低分子医薬品のライフサイクル全体を前進させます。ワンストップショップのソリューション、柔軟性、可用性、デジタル変革を提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の低分子CMO/CDMO市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 低分子医薬品
• 低分子API
• 世界の低分子CMO/CDMO市場、段階タイプ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 臨床
• 商業
• 前臨床
• 世界の低分子CMO/CDMO市場、治療領域別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 腫瘍学
• 神経内科
• 感染症
• 循環器疾患
• 呼吸器疾患
• 代謝障害
• その他の治療
• 世界の低分子CMO/CDMO市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 心臓血管
• 腫瘍学
• 糖尿病
• 免疫疾患

第7章 地域および国の分析

• 世界の低分子CMO/CDMO市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の低分子CMO/CDMO市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 低分子CMO/CDMO市場の競合情勢
• 低分子CMO/CDMO市場の企業プロファイル
  • Patheon NV（Thermo Fisher Scientific）
  • GlaxoSmithKline
  • Johnson Matthey plc
  • Lonza Group Ltd.
  • WuXi AppTec

第31章 その他の主要および革新的な企業

• Catalent Inc.
• Aurobindo Pharma
• Fareva
• Aesica Pharmaceuticals Limited
• Siegfried holdings AG
• Recipharm AB
• Jubilant Life Sciences Limited
• Almac Group
• Piramal Pharma Solutions
• Oxford Chemicals Inc.
• Syngene International Limited
• Novasep
• Pfizer CentreOne
• GVK Biosciences
• ChemPartner

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

A small-molecule Contract Manufacturing Organization (CMO) or Contract Development and Manufacturing Organization (CDMO) is a business entity that offers services to pharmaceutical companies on a contractual basis. These services encompass various aspects of the pharmaceutical development lifecycle, including contract development, manufacturing, and packaging of small-molecule drugs. Small-molecule CMOs/CDMOs play a crucial role in assisting other companies in the pharmaceutical industry to complete projects and navigate through the regulatory submission process.

Small-molecule Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs) are primarily classified into two categories, small-molecule drug products and small-molecule Active Pharmaceutical Ingredient (API). The term "small-molecule drug product" denotes the final form of a medicinal product that incorporates an active pharmaceutical ingredient composed of small molecules. This involves comprehensive stages, including clinical, commercial, and preclinical development. These drug products find applications in therapeutic areas such as oncology, neurology, infectious diseases, cardiovascular diseases, respiratory disorders, metabolic disorders, among others. The end-users of these services are entities specializing in cardiovascular, oncology, diabetes, and immunological disorders.

The small-molecule CMO/CDMO market research report is one of a series of new reports from The Business Research Company that provides small-molecule CMO/CDMO market statistics, including small-molecule CMO/CDMO industry global market size, regional shares, competitors with a small-molecule CMO/CDMO market share, detailed small-molecule CMO/CDMO market segments, market trends and opportunities, and any further data you may need to thrive in the small-molecule CMO/CDMO industry. This small-molecule CMO/CDMO market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The small molecule CMO/CDMO market size has grown strongly in recent years. It will grow from $46.83 billion in 2023 to $50.58 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth observed in the historic period can be attributed to several factors, including favorable government support, the adoption of cost-effective solutions, the increasing complexity in drug development processes, industry consolidation, and a strategic focus on core competencies. These elements collectively contributed to the positive trajectory and expansion of small-molecule Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs) during the historic period.

The small molecule CMO/CDMO market size is expected to see strong growth in the next few years. It will grow to $68.04 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The anticipated growth in the forecast period can be attributed to factors such as the rise in drug pipelines, globalization of pharmaceutical operations, increasing demand for flexible manufacturing solutions, expertise in regulatory compliance, and the convergence of biopharmaceuticals. Key trends expected in the forecast period include the adoption of sustainable and green manufacturing practices, increased collaboration and partnerships within the industry, a focus on personalized medicine and niche therapies, the emergence of virtual and virtual-to-reality companies, integration of digital technologies, and the implementation of rapid response manufacturing strategies.

The small-molecule CMO/CDMO market is expected to experience growth due to the rising demand for pharmaceuticals. The pharmaceutical industry involves the discovery, development, and production of drugs and medicines by various entities, both governmental and private. Small-molecule CMO/CDMO services in the pharmaceutical industry are utilized to outsource tasks such as the development, manufacturing, and packaging of small-molecule drugs. This outsourcing allows pharmaceutical companies to reduce costs, save time, and streamline their processes. According to reports from IQVIA Inc. in May 2021, the projected total expenditure on pharmaceuticals in the US is anticipated to range between $380 to $400 billion by 2025, reflecting a compound annual growth rate of 3% from $359 billion in 2020. This projection indicates a growing demand for pharmaceuticals and, consequently, drives the growth of the small-molecule CMO/CDMO market.

Major companies in the small-molecule CMO/CDMO market are focusing on innovative technologies to enhance CDMO services, such as the state-of-the-art small-molecule platform in Shanghai. This platform represents cutting-edge technological innovations aimed at developing and producing small-molecule drugs more efficiently. In June 2023, Porton Pharma Solutions Ltd., a China-based pharmaceutical company, launched a state-of-the-art small-molecule platform in Shanghai. This platform adopts a holistic approach by combining advanced technologies and methodologies to advance the entire lifecycle of small-molecule pharmaceuticals. It offers one-stop-shop solutions, flexibility, availability, and digital transformation.

In March 2023, Catalent Inc., a US-based pharmaceutical company, entered into a partnership with Grunentha GmbH, a Germany-based pharmaceutical company. This partnership is focused on expediting clinical development timelines for an orally dosed small molecule in Grunenthal's pipeline. The collaboration aims to improve the bioavailability of the small molecule and reduce the Phase 1 development timeline. Grunenthal GmbH is actively engaged in partnerships and agreements with contract development and manufacturing organizations (CDMOs).

Major companies operating in the small molecule CMO/CDMO market report are Patheon NV (Thermo Fisher Scientific), GlaxoSmithKline, Johnson Matthey plc, Lonza Group Ltd., WuXi AppTec, Catalent Inc., Aurobindo Pharma, Fareva, Aesica Pharmaceuticals Limited, Siegfried holdings AG, Recipharm AB, Jubilant Life Sciences Limited, Almac Group, Piramal Pharma Solutions, Oxford Chemicals Inc., Syngene International Limited, Novasep, Pfizer CentreOne, GVK Biosciences, ChemPartner, Avid Bioservices Inc., Dishman Carbogen Amcis Ltd, ProChem Inc., Metrics Contract Services

North America was the largest region in the Small Molecule CMO/CDMO market in 2023. The regions covered in the Small Molecule CMO/CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the Small Molecule CMO/CDMO market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The small-molecule contract manufacturing organization (CMO) or contract development and manufacturing organization (CDMO) market consists of revenues earned by entities by providing services such as drug development services, process scale-up, quality control and testing, technology transfer, and clinical trial support. The market value includes the value of related goods sold by the service provider or included within the service offering. The small-molecule contract manufacturing organization (CMO) or contract development and manufacturing organization (CDMO) market also includes sales of active pharmaceutical ingredients, drug intermediates, and drug formulation. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Small Molecule CMO/CDMO Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on small molecule cmo/cdmo market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for small molecule cmo/cdmo ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The small molecule cmo/cdmo market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Small Molecule Drug Product; Small Molecule API
• 2) By Stage Type: Clinical; Commercial; Preclinical
• 3) By Therapeutic Area: Oncology; Neurology; Infectious Disease; Cardiovascular Disease; Respiratory Disorders; Metabolic Disorders; Other Therapeutics
• 4) By Application: Cardiovascular; Oncology; Diabetes; Immunological Disorders
• Companies Mentioned: Patheon NV (Thermo Fisher Scientific); GlaxoSmithKline; Johnson Matthey plc; Lonza Group Ltd.; WuXi AppTec
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Small Molecule CMO/CDMO Market Characteristics

3. Small Molecule CMO/CDMO Market Trends And Strategies

4. Small Molecule CMO/CDMO Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Small Molecule CMO/CDMO Market Size and Growth

• 5.1. Global Small Molecule CMO/CDMO Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Small Molecule CMO/CDMO Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Small Molecule CMO/CDMO Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Small Molecule CMO/CDMO Market Segmentation

• 6.1. Global Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Small Molecule Drug Product
• Small Molecule API
• 6.2. Global Small Molecule CMO/CDMO Market, Segmentation By Stage Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Clinical
• Commercial
• Preclinical
• 6.3. Global Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oncology
• Neurology
• Infectious Disease
• Cardiovascular Disease
• Respiratory Disorders
• Metabolic Disorders
• Other Therapeutics
• 6.4. Global Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Cardiovascular
• Oncology
• Diabetes
• Immunological Disorders

7. Small Molecule CMO/CDMO Market Regional And Country Analysis

• 7.1. Global Small Molecule CMO/CDMO Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Small Molecule CMO/CDMO Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Small Molecule CMO/CDMO Market

• 8.1. Asia-Pacific Small Molecule CMO/CDMO Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Small Molecule CMO/CDMO Market

• 9.1. China Small Molecule CMO/CDMO Market Overview
• 9.2. China Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Small Molecule CMO/CDMO Market

• 10.1. India Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Small Molecule CMO/CDMO Market

• 11.1. Japan Small Molecule CMO/CDMO Market Overview
• 11.2. Japan Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Small Molecule CMO/CDMO Market

• 12.1. Australia Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Small Molecule CMO/CDMO Market

• 13.1. Indonesia Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Small Molecule CMO/CDMO Market

• 14.1. South Korea Small Molecule CMO/CDMO Market Overview
• 14.2. South Korea Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Small Molecule CMO/CDMO Market

• 15.1. Western Europe Small Molecule CMO/CDMO Market Overview
• 15.2. Western Europe Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Small Molecule CMO/CDMO Market

• 16.1. UK Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Small Molecule CMO/CDMO Market

• 17.1. Germany Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Small Molecule CMO/CDMO Market

• 18.1. France Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Small Molecule CMO/CDMO Market

• 19.1. Italy Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Small Molecule CMO/CDMO Market

• 20.1. Spain Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Small Molecule CMO/CDMO Market

• 21.1. Eastern Europe Small Molecule CMO/CDMO Market Overview
• 21.2. Eastern Europe Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Small Molecule CMO/CDMO Market

• 22.1. Russia Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Small Molecule CMO/CDMO Market

• 23.1. North America Small Molecule CMO/CDMO Market Overview
• 23.2. North America Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Small Molecule CMO/CDMO Market

• 24.1. USA Small Molecule CMO/CDMO Market Overview
• 24.2. USA Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Small Molecule CMO/CDMO Market

• 25.1. Canada Small Molecule CMO/CDMO Market Overview
• 25.2. Canada Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Small Molecule CMO/CDMO Market

• 26.1. South America Small Molecule CMO/CDMO Market Overview
• 26.2. South America Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Small Molecule CMO/CDMO Market

• 27.1. Brazil Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Small Molecule CMO/CDMO Market

• 28.1. Middle East Small Molecule CMO/CDMO Market Overview
• 28.2. Middle East Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Small Molecule CMO/CDMO Market

• 29.1. Africa Small Molecule CMO/CDMO Market Overview
• 29.2. Africa Small Molecule CMO/CDMO Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Small Molecule CMO/CDMO Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Small Molecule CMO/CDMO Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Small Molecule CMO/CDMO Market Competitive Landscape And Company Profiles

• 30.1. Small Molecule CMO/CDMO Market Competitive Landscape
• 30.2. Small Molecule CMO/CDMO Market Company Profiles
  • 30.2.1. Patheon NV (Thermo Fisher Scientific)
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. GlaxoSmithKline
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Johnson Matthey plc
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Lonza Group Ltd.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. WuXi AppTec
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Small Molecule CMO/CDMO Market Other Major And Innovative Companies

• 31.1. Catalent Inc.
• 31.2. Aurobindo Pharma
• 31.3. Fareva
• 31.4. Aesica Pharmaceuticals Limited
• 31.5. Siegfried holdings AG
• 31.6. Recipharm AB
• 31.7. Jubilant Life Sciences Limited
• 31.8. Almac Group
• 31.9. Piramal Pharma Solutions
• 31.10. Oxford Chemicals Inc.
• 31.11. Syngene International Limited
• 31.12. Novasep
• 31.13. Pfizer CentreOne
• 31.14. GVK Biosciences
• 31.15. ChemPartner

32. Global Small Molecule CMO/CDMO Market Competitive Benchmarking

33. Global Small Molecule CMO/CDMO Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Small Molecule CMO/CDMO Market

35. Small Molecule CMO/CDMO Market Future Outlook and Potential Analysis

• 35.1 Small Molecule CMO/CDMO Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Small Molecule CMO/CDMO Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Small Molecule CMO/CDMO Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer